Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

79974 ARTíCULOS , VIENDO DEL 76126 AL 76140

PUBMED

Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson's Disease.

Nguyen M, Wong YC, Ysselstein D, Severino A, Krainc D.

Trends Neurosci. 2018 Nov 30. pii: S0166-2236(18)30282-0. doi: 10.1016/j.tins.2018.11.001. [Epub ahead of print] Review.

0

0

0

PUBMED

What makes a group fitness program for people with Parkinson's disease endure? A mixed-methods study of multiple stakeholders.

Rossi A, Torres-Panchame R, Gallo PM, Marcus AR, States RA.

Complement Ther Med. 2018 Dec;41:320-327. doi: 10.1016/j.ctim.2018.08.012. Epub 2018 Aug 31.

0

0

0

PUBMED

Music Therapy in Parkinson's Disease.

García-Casares N, Martín-Colom JE, García-Arnés JA.

J Am Med Dir Assoc. 2018 Dec;19(12):1054-1062. doi: 10.1016/j.jamda.2018.09.025. Review.

0

0

0

PUBMED

Developing and validating Parkinson's disease subtypes and their motor and cognitive progression.

Lawton M, Ben-Shlomo Y, May MT, Baig F, Barber TR, Klein JC, Swallow DMA, Malek N, Grosset KA, Bajaj N, Barker RA, Williams N, Burn DJ, Foltynie T, Morris HR, Wood NW, Grosset DG, Hu MTM.

J Neurol Neurosurg Psychiatry. 2018 Dec;89(12):1279-1287. doi: 10.1136/jnnp-2018-318337. Epub 2018 Jul 25.

0

0

0

PUBMED

Peripheral blood inflammatory markers in early Parkinson's disease.

Kim R, Kim HJ, Kim A, Jang M, Kim A, Kim Y, Yoo D, Im JH, Choi JH, Jeon B.

J Clin Neurosci. 2018 Dec;58:30-33. doi: 10.1016/j.jocn.2018.10.079. Epub 2018 Oct 24.

0

0

0

PUBMED

Parkinson disease: A systemic review of pain sensitivities and its association with clinical pain and response to dopaminergic stimulation.

Sung S, Vijiaratnam N, Chan DWC, Farrell M, Evans AH.

J Neurol Sci. 2018 Dec 15;395:172-206. doi: 10.1016/j.jns.2018.10.013. Epub 2018 Oct 19. Review.

0

0

0

PUBMED

Corrigendum to Phenylalanine hydroxylase: A biomarker of disease susceptibility in Parkinson's disease and amyotrophic lateral sclerosis" [Med. Hypotheses 118 (2018) 29-33]."

Steventon GB, Mitchell SC.

Med Hypotheses. 2018 Dec;121:88. doi: 10.1016/j.mehy.2018.09.030. Epub 2018 Sep 25. No abstract available.

0

0

0

PUBMED

Neuroimaging advances in Parkinson's disease: Erratum.

[No authors listed]

Curr Opin Neurol. 2018 Dec;31(6):760. doi: 10.1097/WCO.0000000000000628. No abstract available.

0

0

0

PUBMED

Safranal-promoted differentiation and survival of dopaminergic neurons in an animal model of Parkinson's disease.

Zhao Y, Xi G.

Pharm Biol. 2018 Dec;56(1):450-454. doi: 10.1080/13880209.2018.1501705.

0

0

0

PUBMED

Identifying mild-moderate Parkinson's disease using whole-brain functional connectivity.

Tang Y, Liu B, Yang Y, Wang CM, Meng L, Tang BS, Guo JF.

Clin Neurophysiol. 2018 Dec;129(12):2507-2516. doi: 10.1016/j.clinph.2018.09.006. Epub 2018 Sep 24.

0

0

0

PUBMED

Higher serum triglyceride levels are associated with Parkinson's disease mild cognitive impairment.

Huang X, Ng SY, Chia NS, Acharyya S, Setiawan F, Lu Z, Tan YJ, Ng E, Wen MC, Ng ASL, Tay KY, Au WL, Tan EK, Tan LC.

Mov Disord. 2018 Dec;33(12):1970-1971. doi: 10.1002/mds.27521. Epub 2018 Oct 21. No abstract available.

0

0

0

PUBMED

Pharmacokinetics and safety/efficacy of levodopa pro-drug ONO-2160/carbidopa for Parkinson's disease.

Nomoto M, Nagai M, Nishikawa N, Ando R, Kagamiishi Y, Yano K, Saito S, Takeda A.

eNeurologicalSci. 2018 Sep 17;13:8-13. doi: 10.1016/j.ensci.2018.09.003. eCollection 2018 Dec.

0

0

0

PUBMED

Proanthocyanidins exert a neuroprotective effect via ROS/JNK signaling in MPTP‑induced Parkinson's disease models in vitro and in vivo.

Chen H, Xu J, Lv Y, He P, Liu C, Jiao J, Li S, Mao X, Xue X.

Mol Med Rep. 2018 Dec;18(6):4913-4921. doi: 10.3892/mmr.2018.9509. Epub 2018 Sep 25.

0

0

0

PUBMED

Corrigendum to Interleukin-1β, interleukin-1 receptor antagonist, interleukin-6, interleukin-10, and tumor necrosis factor-α levels in CSF and serum in relation to the clinical diversity of Parkinson's disease [Cell. Immunol. 327 (2018) 77-82].

Karpenko MN, Vasilishina AA, Gromova EA, Muruzheva ZM, Bernadotte A.

Cell Immunol. 2018 Dec;334:99. doi: 10.1016/j.cellimm.2018.08.007. Epub 2018 Sep 10. No abstract available.

0

0

0

PUBMED

Quantifying turning behavior and gait in Parkinson's disease using mobile technology.

Miller Koop M, Ozinga SJ, Rosenfeldt AB, Alberts JL.

IBRO Rep. 2018 Jun 21;5:10-16. doi: 10.1016/j.ibror.2018.06.002. eCollection 2018 Dec.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy